TITLE

Resolution of pulmonary nodules in Hodgkin's disease and HIV

AUTHOR(S)
Wasserman, Carrie; Goel, Anupama; Ghesani, Munir
PUB. DATE
September 2008
SOURCE
Hem/Onc Today;9/10/2008, Vol. 9 Issue 16, p6
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses the application of highly active antiretroviral therapy (HAART) and chemotherapy on patients with Hodgkin's disease and human immunodeficiency virus (HIV). It cites a case of a 40-year-old man diagnosed with HIV infection on routine screening in 2005. On the initial hospitalization, the application of HAART continued along with the initial use of prophylactic antibiotics. The patient also had an ABVD treatment in May 2008.
ACCESSION #
34154569

 

Related Articles

  • Hodgkin Lymphoma in HIV Positive Patients. Mounier, Nicolas; Spina, Michele; Spano, Jean P. // Current HIV Research;Mar2010, Vol. 8 Issue 2, p141 

    Hodgkin Lymphoma (HL) represents one of the most common types of a non-AIDS-defining tumour that occurs in the HIV population, and its incidence is increasing in the post Highly Active Anti-retroviral Therapy (HAART) era. Despite the aggressiveness of that disease, the outcome of patients with...

  • Hodgkin's Disease in Patients with HIV Infection. Spina, Michele; Carbone, Antonino; Gloghini, Annunziata; Serraino, Diego; Berretta, Massimiliano; Tirelli, Umberto // Advances in Hematology;2011, Vol. 2011, p1 

    Hodgkin lymphoma (HL) represents one of the most common non-AIDS-defining cancers with an increasing incidence overtime. Clinically, patients present advanced stages of disease with extranodal involvement in the majority of cases. In the last years, significant improvements in the treatment of...

  • Penetration and Effectiveness of Antiretroviral Therapy in the Central Nervous System. Letendre, Scott; Ellis, Ronald J.; Best, Brookie; Bhatt, Archana; Marquie-Beck, Jennifer; LeBlanc, Shannon; Rossi, Steven; Capparelli, Edmund; McCutchan, J. Allen // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Jun2009, Vol. 8 Issue 2, p169 

    Combination antiretroviral therapy (ART) has markedly reduced morbidity and mortality among HIV-infected individuals but not the prevalence of HIV-associated neurocognitive disorders (HAND). Several conditions may be responsible for the high prevalence of cognitive impairment, including...

  • Structured Treatment Interruption in Patients Infected with HIV: A New Approach to Therapy? Gulick, Roy M. // Drugs;2002, Vol. 62 Issue 4, p245 

    Current antiretroviral regimens are limited by issues of potency, adherence, toxicity, resistance and cost. With these limitations and the realisation that eradication of HIV infection currently is not possible, there is enthusiasm for strategies that allow discontinuation of medications, such...

  • The future of antiretroviral therapy: challenges and needs. Moreno, Santiago; López Aldeguer, Jose; Arribas, José Ramón; Domingo, Pere; Iribarren, Jose Antonio; Ribera, Esteban; Rivero, Antonio; Pulido, Federico // Journal of Antimicrobial Chemotherapy (JAC);May2010, Vol. 65 Issue 5, p827 

    The introduction of combination antiretroviral therapy (cART) has substantially modified the natural history of HIV infection. At the beginning of the cART era the objective was focused on HIV-1-associated mortality and morbidity, but as this objective was accomplished other issues emerged,...

  • When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis. Torok, Mili E. // Current Respiratory Medicine Reviews;Jun2013, Vol. 9 Issue 3, p193 

    The optimal time to initiate antiretroviral therapy (ART) in patients presenting with HIV-associated tuberculosis has been a controversial issue. Early initiation of ART may be complicated by high pill burden, overlapping drug toxicities, and an increased risk of immune reconstitution...

  • Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Gutierrez, Absalon; Balasubramanyam, Ashok // Endocrine (1355008X);Feb2012, Vol. 41 Issue 1, p1 

    HIV-infected patients on highly active antiretroviral therapy (HAART) have increased prevalence of a number of chronic metabolic disorders of multifactorial but unclear etiology. These include disorders of lipid metabolism with or without lipodystrophy, insulin resistance, and an increased...

  • An Investigation of the Determinants of Adherence to Highly Active Anti-Retroviral Therapy (HAART) in Aboriginal Men in the Downtown Eastside (DTES) of Vancouver. Chongo, Meck; Lavoie, Josée G.; Hoffman, Ross; Shubair, Mamdouh // Canadian Journal of Aboriginal Community-Based HIV/AIDS Research;Winter2011, Vol. 4, p32 

    The eradication of HIV is not yet possible; therefore persons undergoing treatment must take highly active antiretroviral therapy (HAART) regularly. In British Columbia (BC), antiretrovirals are distributed at no cost but the HIV-related annual mortality rate stands at 9% (Vancouver Native Heath...

  • Longer Use of Combination Antiretroviral Therapy Associated with Reduced Risk of Cervical HPV. London, S. // International Perspectives on Sexual & Reproductive Health;Mar2015, Vol. 41 Issue 1, p55 

    The article discusses a study which showed that women infected with HIV may have a lower risk of testing positive for cervical human papillomavirus (HPV) if they were taking a combination antiretroviral therapy (cART). Topics discussed include the use of bivariate analyses to compare baseline...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics